{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:01:00Z","timestamp":1790456460365,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2019\/001483"],"award-info":[{"award-number":["CRG\/2019\/001483"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2019\/004018"],"award-info":[{"award-number":["CRG\/2019\/004018"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017009","name":"Institute of Nano Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["45\/6\/2019-Nan\/BMS"],"award-info":[{"award-number":["45\/6\/2019-Nan\/BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Science and Engineering: C"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.msec.2020.111851","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T20:50:14Z","timestamp":1610139014000},"page":"111851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Enema based therapy using liposomal formulation of low molecular weight heparin for treatment of active ulcerative colitis: New adjunct therapeutic opportunity"],"prefix":"10.1016","volume":"121","author":[{"given":"Anas","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpesh","family":"Vaghasiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravej","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Shadab","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul Kumar","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehan","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msec.2020.111851_bb0005","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1517\/14656566.5.2.329","article-title":"Drug treatment of ulcerative colitis: unfractionated heparin, low molecular weight heparins and beyond","volume":"5","author":"Malhotra","year":"2004","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.msec.2020.111851_bb0010","first-page":"357","article-title":"Definition and epidemiology of inflammatory bowel disease","volume":"75","author":"Fujii","year":"2017","journal-title":"Nippon Rinsho"},{"key":"10.1016\/j.msec.2020.111851_bb0015","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrgastro.2011.96","article-title":"Pathogenesis and biomarkers of carcinogenesis in ulcerative colitis","volume":"8","author":"Thorsteinsdottir","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.msec.2020.111851_bb0020","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.aat0835","article-title":"Intestinal barriers protect against disease","volume":"359","author":"Citi","year":"2018","journal-title":"Science."},{"key":"10.1016\/j.msec.2020.111851_bb0025","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nri2653","article-title":"Intestinal mucosal barrier function in health and disease","volume":"9","author":"Turner","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.msec.2020.111851_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nmicrobiol.2017.4","article-title":"Dynamics of the human gut microbiome in inflammatory bowel disease","volume":"2","author":"Halfvarson","year":"2017","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.msec.2020.111851_bb0035","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nri2515","article-title":"The gut microbiota shapes intestinal immune responses during health and disease","volume":"9","author":"Round","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.msec.2020.111851_bb0040","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.gene.2013.11.081","article-title":"Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity","volume":"537","author":"Remely","year":"2014","journal-title":"Gene."},{"key":"10.1016\/j.msec.2020.111851_bb0045","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1373\/clinchem.2012.187617","article-title":"The human gut microbiome and body metabolism: implications for obesity and diabetes","volume":"59","author":"Devaraj","year":"2013","journal-title":"Clin. Chem."},{"key":"10.1016\/j.msec.2020.111851_bb0050","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.9b09125","article-title":"Amyloid\u2013polyphenol hybrid nanofilaments mitigate colitis and regulate gut microbial dysbiosis","author":"Hu","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.msec.2020.111851_bb0055","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41563-019-0462-9","article-title":"Hyaluronic acid\u2013bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis","volume":"19","author":"Lee","year":"2020","journal-title":"Nat. Mater."},{"key":"10.1016\/j.msec.2020.111851_bb0060","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.apsb.2016.07.012","article-title":"An update on the role of intestinal cytochrome P450 enzymes in drug disposition","volume":"6","author":"Xie","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.msec.2020.111851_bb0065","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jsps.2012.03.005","article-title":"Loss of orally administered drugs in GI tract","volume":"20","author":"Gavhane","year":"2012","journal-title":"Saudi Pharm J."},{"key":"10.1016\/j.msec.2020.111851_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/s41424-018-0013-8","article-title":"Risk of thrombosis and mortality in inflammatory bowel disease","volume":"9","author":"Andrade","year":"2018","journal-title":"Clin Transl Gastroenterol."},{"key":"10.1016\/j.msec.2020.111851_bb0075","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/gast.2000.18159","article-title":"Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis","volume":"119","author":"Pan\u00e9s","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.msec.2020.111851_bb0080","doi-asserted-by":"crossref","first-page":"6617","DOI":"10.1021\/acsbiomaterials.9b01486","article-title":"Heparin-encapsulated metered-dose topical \u201cNano-spray gel\u201d liposomal formulation ensures rapid on-site management of frostbite injury by inflammatory cytokines scavenging","volume":"5","author":"Vaghasiya","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.msec.2020.111851_bb0085","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S0140-6736(05)76915-4","article-title":"Heparin and inflammatory bowel disease","volume":"354","author":"White","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.msec.2020.111851_bb0090","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/10717544.2017.1324530","article-title":"Nanoparticle-based delivery enhances anti-inflammatory effect of low molecular weight heparin in experimental ulcerative colitis","volume":"24","author":"Yazeji","year":"2017","journal-title":"Drug Delivery."},{"key":"10.1016\/j.msec.2020.111851_bb0095","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.msec.2017.07.037","article-title":"Preparation, characterization and anti-colitis activity of curcumin-asafoetida complex encapsulated in turmeric nanofiber","volume":"81","author":"Gopi","year":"2017","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.msec.2020.111851_bb0100","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.msec.2018.08.033","article-title":"Effect of \u042160 fullerenes on the intensity of colon damage and hematological signs of ulcerative colitis in rats","volume":"93","author":"Byelinska","year":"2018","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.msec.2020.111851_bb0105","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.msec.2018.12.127","article-title":"Fabrication of alginate-based stimuli-responsive, non-cytotoxic, terpolymric semi-IPN hydrogel as a carrier for controlled release of bovine albumin serum and 5-amino salicylic acid","volume":"98","author":"Das","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.msec.2020.111851_bb0110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12951-020-0579-7","article-title":"Ternary nanocomposite carriers based on organic clay-lipid vesicles as an effective colon-targeted drug delivery system: preparation and in vitro\/in vivo characterization","volume":"18","author":"Kim","year":"2020","journal-title":"J Nanobiotechnol."},{"key":"10.1016\/j.msec.2020.111851_bb0115","doi-asserted-by":"crossref","first-page":"119617","DOI":"10.1016\/j.ijpharm.2020.119617","article-title":"Oxymatrine loaded nitric oxide-releasing liposomes for the treatment of ulcerative colitis","volume":"586","author":"Tang","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msec.2020.111851_bb0120","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2147\/IJN.S42153","article-title":"Application of liposomes in drug development \u2014 focus on gastroenterological targets","volume":"8","author":"Zhang","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.msec.2020.111851_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024202","article-title":"Enhanced transferrin receptor expression by proinflammatory cytokines in enterocytes as a means for local delivery of drugs to inflamed gut mucosa","volume":"6","author":"Harel","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.msec.2020.111851_bb0130","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1021\/mp9000926","article-title":"Transferrin as a luminal target for negatively charged liposomes in the inflamed colonic mucosa","volume":"6","author":"Tirosh","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.msec.2020.111851_bb0135","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/mp0499095","article-title":"Local prevention of oxidative stress in the intestinal epithelium of the rat by adhesive liposomes of superoxide dismutase and Tempamine","volume":"2","author":"Jubeh","year":"2005","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.msec.2020.111851_bb0145","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1021\/acsbiomaterials.9b01947","article-title":"Hyperbranched polymer-functionalized magnetic nanoparticle-mediated hyperthermia and niclosamide bimodal therapy of colorectal cancer cells","volume":"6","author":"Ahmad","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.msec.2020.111851_bb0150","article-title":"Lipid-based nanocarrier-mediated targeted delivery of celecoxib attenuate severity of ulcerative colitis","volume":"111103","author":"Mishra","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.msec.2020.111851_bb0155","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1021\/acsbiomaterials.9b00427","article-title":"Zinc gluconate-loaded chitosan nanoparticles reduce severity of collagen-induced arthritis in Wistar rats","volume":"5","author":"Ansari","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.msec.2020.111851_bb0160","doi-asserted-by":"crossref","first-page":"111582","DOI":"10.1016\/j.msec.2020.111582","article-title":"Enteric-coated gelatin nanoparticles mediated oral delivery of 5-aminosalicylic acid alleviates severity of DSS-induced ulcerative colitis","volume":"119","author":"Ahmad","year":"2021","journal-title":"Materials Science and Engineering: C"},{"key":"10.1016\/j.msec.2020.111851_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics8040036","article-title":"Evaluation of extrusion technique for nanosizing liposomes","volume":"8","author":"Ong","year":"2016","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.msec.2020.111851_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220156","article-title":"Pharmacological inhibition of NPY receptors illustrates dissociable features of experimental colitis in the mouse DSS model: implications for preclinical evaluation of efficacy in an inflammatory bowel disease model","volume":"14","author":"Ruiz","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.msec.2020.111851_bb0175","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bcp.2019.01.001","article-title":"Systemic administration of serotonin exacerbates abdominal pain and colitis via interaction with the endocannabinoid system","volume":"161","author":"Salaga","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.msec.2020.111851_bb0180","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41590-020-0621-9","article-title":"Two distinct ubiquitin-binding motifs in A20 mediate its anti-inflammatory and cell-protective activities","volume":"21","author":"Martens","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.msec.2020.111851_bb0185","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.3748\/wjg.v23.i33.6016","article-title":"Dextran sodium sulfate colitis murine model: an indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis","volume":"23","author":"Eichele","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.msec.2020.111851_bb0190","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.4049\/jimmunol.1402300","article-title":"Porcine \u03b2-defensin 2 attenuates inflammation and mucosal lesions in dextran sodium sulfate\u2013induced colitis","volume":"194","author":"Han","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.msec.2020.111851_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024447","article-title":"On the relationship between sialomucin and sulfomucin expression and hydrogenotrophic microbes in the human colonic mucosa","volume":"6","author":"Croix","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.msec.2020.111851_bb0200","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1590\/s0102-865020170030000002","article-title":"Tissue sulfomucin and sialomucin content in colon mucosa without intestinal transit subjected to intervention with Curcuma longa (curcumin)","volume":"32","author":"Alves J\u00fanior","year":"2017","journal-title":"Acta Cirurgica Brasileira."},{"key":"10.1016\/j.msec.2020.111851_bb0205","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/s41590-019-0493-z","article-title":"House dust mites activate nociceptor-mast cell clusters to drive type 2 skin inflammation","volume":"20","author":"Serhan","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.msec.2020.111851_bb0210","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nri3690","article-title":"Mast cell secretory granules: armed for battle","volume":"14","author":"Wernersson","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.msec.2020.111851_bb0215","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1097\/MIB.0000000000000142","article-title":"The multifaceted mast cell in inflammatory bowel disease","volume":"20","author":"Hamilton","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.msec.2020.111851_bb0220","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3748\/wjg.v10.i3.309","article-title":"Key role of mast cells and their major secretory products in inflammatory bowel disease","volume":"10","author":"He","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.msec.2020.111851_bb0225","doi-asserted-by":"crossref","first-page":"68108","DOI":"10.18632\/oncotarget.19202","article-title":"Markers of inflammation and influence of nitric oxide on platelet activation in the course of ulcerative colitis","volume":"8","author":"Gawro\u0144ska","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.msec.2020.111851_bb0230","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4292\/wjgpt.v7.i3.353","article-title":"Overview of cytokines and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel diseases","volume":"7","author":"Soufli","year":"2016","journal-title":"World J Gastrointest Pharmacol Ther."},{"key":"10.1016\/j.msec.2020.111851_bb0235","doi-asserted-by":"crossref","first-page":"5","DOI":"10.17305\/bjbms.2013.2402","article-title":"Nitric oxide as a potential biomarker in inflammatory bowel disease","volume":"13","author":"Avdagi\u0107","year":"2013","journal-title":"Bosn J Basic Med Sci."},{"key":"10.1016\/j.msec.2020.111851_bb0240","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3109\/00365529509096328","article-title":"Serum nitrate levels in ulcerative colitis and Crohn\u2019s disease","volume":"30","author":"Pool","year":"1995","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.msec.2020.111851_bb0245","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.abb.2018.03.012","article-title":"Myeloperoxidase in the inflamed colon: a novel target for treating inflammatory bowel disease","volume":"645","author":"Chami","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.msec.2020.111851_bb0250","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ibd.21681","article-title":"Myeloperoxidase immunohistochemistry as a measure of disease activity in ulcerative colitis: association with ulcerative colitis-colorectal cancer, tumor necrosis factor polymorphism and RUNX3 methylation","volume":"18","author":"Garrity-Park","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.msec.2020.111851_bb0255","doi-asserted-by":"crossref","DOI":"10.1186\/s12906-016-1057-5","article-title":"Effect of turmeric on colon histology, body weight, ulcer, IL-23, MPO and glutathione in acetic-acid-induced inflammatory bowel disease in rats","volume":"16","author":"Bastaki","year":"2016","journal-title":"BMC Complement Altern Med."},{"key":"10.1016\/j.msec.2020.111851_bb0260","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejpb.2018.01.016","article-title":"Inflamed site-specific drug delivery system based on the interaction of human serum albumin nanoparticles with myeloperoxidase in a murine model of experimental colitis","volume":"125","author":"Iwao","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.msec.2020.111851_bb0265","doi-asserted-by":"crossref","unstructured":"D.R. Hansberry, K. Shah, P. Agarwal, N. Agarwal, Fecal myeloperoxidase as a biomarker for inflammatory bowel disease, Cureus. 9 (n.d.). doi:https:\/\/doi.org\/10.7759\/cureus.1004.","DOI":"10.7759\/cureus.1004"},{"key":"10.1016\/j.msec.2020.111851_bb0270","doi-asserted-by":"crossref","first-page":"109763","DOI":"10.1016\/j.msec.2019.109763","article-title":"In vitro and in vivo toxicity assessment of selenium nanoparticles with significant larvicidal and bacteriostatic properties","volume":"103","author":"Yazhiniprabha","year":"2019","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.msec.2020.111851_bb0275","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.msec.2018.07.064","article-title":"Formulation, characterization, and in vitro\/in vivo studies of capsaicin-loaded albumin nanoparticles","volume":"93","author":"De Freitas","year":"2018","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.msec.2020.111851_bb0280","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.msec.2018.05.048","article-title":"Green synthesized silver nanoparticles: catalytic dye degradation, in vitro anticancer activity and in vivo toxicity in rats","volume":"91","author":"Nakkala","year":"2018","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.msec.2020.111851_bb0285","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.msec.2016.10.023","article-title":"In vitro and in vivo assessment of nanotoxicity of CdS quantum dot\/aminopolysaccharide bionanoconjugates","volume":"71","author":"de Carvalho","year":"2017","journal-title":"Mater Sci Eng C Mater Biol Appl."},{"key":"10.1016\/j.msec.2020.111851_bb0290","doi-asserted-by":"crossref","unstructured":"A. Ahmad, M.M. Ansari, A. Kumar, A. Vyawahare, R.K. Mishra, G. Jayamurugan, S.S. Raza, R. Khan, Comparative acute intravenous toxicity study of triple polymer-layered magnetic nanoparticles with bare magnetic nanoparticles in Swiss albino mice, Nanotoxicology. 0 (2020) 1\u201319. doi:https:\/\/doi.org\/10.1080\/17435390.2020.1829144.","DOI":"10.1080\/17435390.2020.1829144"}],"container-title":["Materials Science and Engineering: C"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092849312033770X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092849312033770X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:46:39Z","timestamp":1790455599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092849312033770X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":57,"alternative-id":["S092849312033770X"],"URL":"https:\/\/doi.org\/10.1016\/j.msec.2020.111851","relation":{},"ISSN":["0928-4931"],"issn-type":[{"value":"0928-4931","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enema based therapy using liposomal formulation of low molecular weight heparin for treatment of active ulcerative colitis: New adjunct therapeutic opportunity","name":"articletitle","label":"Article Title"},{"value":"Materials Science and Engineering: C","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msec.2020.111851","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111851"}}